Welcome to Caravan Biologix, where innovation meets purpose in the pursuit of revolutionizing therapeutics. Our journey began as a mere thought experiment, driven by a passion to address the persistent challenges facing whole cell Chimeric Antigen Receptor (CAR) therapeutics in combatting solid tumor cancers.

​

The culmination of our endeavors resulted in the birth of the CAR-directed BioSphere Nanotechnology, appropriately termed the Mini-CAR. This groundbreaking technology stands poised to disrupt conventional paradigms, offering a promising solution for a myriad of human and animal diseases. From solid tumor cancers to hereditary diseases, metabolic disorders to degenerative conditions, and beyond, the potential applications of Mini-CAR are as vast as they are transformative.

​

At Caravan Biologix, our mission is crystal clear - to significantly elevate the efficacy and accessibility of CAR therapeutics. We are driven by a steadfast commitment to advancing our novel Mini-CAR BioSphere Nanotechnology platform, propelling it into a new echelon of therapeutics capable of addressing a spectrum of human ailments. Behind this mission stands a dedicated team of healthcare professionals, united by a shared vision of pioneering change in the field of biomedicine.

​

Join us on this journey as we embark on a path toward reshaping the future of healthcare. Together, we strive to unlock new possibilities in the treatment of diseases, forging a brighter and healthier tomorrow for all. Caravan Biologix - where innovation meets compassion, and where the journey toward better health begins.